Optiwize Inc. OptiWize Health OptiWize Coll Recall (Saf...
Optiwize Inc.'s OptiWize Health OptiWize Collagen Plus has been recalled due to a safety concern. Do not consume this product. Throw it away or return it to the place of purchase for a refund.
By RecallRadar Editorial Team
Sourced from FDA. Last verified March 4, 2026.
On this page
Free checker
Check if you qualify
See whether your device may qualify for a free repair or replacement program before you spend money.
Check if you qualifyKey facts
- Date announced
- September 23, 2025
- Source agency
- FDA
This recall involves safety concerns. Take action promptly.
✨ Plain-English Summary
Optiwize Inc.'s OptiWize Health OptiWize Collagen Plus has been recalled due to a safety concern. Do not consume this product. Throw it away or return it to the place of purchase for a refund.
Is This Recall Still Active?
Status: No - Expired
This recall is no longer active. You can still review details here for historical reference and confirmation.
What's Being Recalled
Quoted source excerpt from the official notice.
The firm initiated a voluntary recall after NSF testing showed that labeled ingredient quantities did not align with analytical test results, manganese level was below label quantity.
Quick Info
Key facts from the official notice, kept in the article flow for easy cross-checking.
- Brand
- Optiwize inc.
- Category
- food
- Source agency
- FDA
- Announced
- September 23, 2025
- Country
- US
- Status
- Expired
Who's Affected
Specific models and identifiers listed in the source notice:
Model #1
OHB25230
| # | Model |
|---|---|
| 1 | OHB25230 |
Technical model codes are manufacturer identifiers. Match both the product name and model code from your device settings, label, or packaging.
What You Should Do
Follow the remedy path from the official notice using the exact model and serial details above.
- 1## OptiWize Health OptiWize Collagen Plus 320 count bottle; White bottle with black lid. Agency: FDA | Category: food | Date: 2025-09-23 Reason: The firm initiated a voluntary recall after NSF testing showed that labeled ingredient quantities did not align with analytical test results, manganese level was below label quantity. What to do:
- 2Stop using the product if it matches your lot/model.
- 3Compare your product details with the FDA recall notice.
- 4Follow the manufacturer's remedy instructions (refund, replacement, or disposal).
This program has ended. The official source page may no longer be available.
Source & Verification
This page summarizes the official notice and keeps key facts easy to verify.
- Official source
- FDA
- Announced by source
- September 23, 2025
- Last reviewed by RecallRadar
- March 4, 2026
Frequently Asked Questions
Am I affected by this recall?
Check the affected models section on this page. The official notice currently lists OHB25230.
What is the remedy for this recall?
## OptiWize Health OptiWize Collagen Plus 320 count bottle; White bottle with black lid. Agency: FDA | Category: food | Date: 2025-09-23 Reason: The firm initiated a voluntary recall after NSF testing showed that labeled ingredient quantities did not align with analytical test results, manganese level was below label quantity. What to do: 1. Stop using the product if it matches your lot/model. 2. Compare your product details with the FDA recall notice. 3. Follow the manufacturer's remedy instructions (refund, replacement, or disposal).
Where can I verify recall details?
Use the official source link in this page to confirm dates, eligibility, and next steps: https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts
Keep browsing with these internal hubs: optiwize inc. recall hub and Food & Drug recall hub.
Official Resources
Use these primary sources for final eligibility and claim instructions.
View official notice from FDASee an inaccuracy?
Help us improve the accuracy of this recall information.
On this page
Free checker
Check if you qualify
See whether your device may qualify for a free repair or replacement program before you spend money.
Check if you qualifyKey facts
- Date announced
- September 23, 2025
- Source agency
- FDA
Related Recalls
Liraglutide Injection, 18 mg/3 mL (6 mg/mL), Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Naples, FL 34108, Manufactured by: Lupin Limited, Nagpur 441108, INDIA, a) 2 Pens- NDC 70748-346-02; b) 3 Pens - NDC 70748-346-03.
Presence of particulate matter: a white thread-like structure in the cartridge
May 27, 2026
Erythromycin Tablets, USP, 500 mg, 30 tablets per bottle, Rx only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534; (NDC 70710-1048-3).
CGMP Deviations; presence of N-Nitroso-Desmethyl-Erythromycin above the recommended acceptable intake limit
May 27, 2026
fentaNYL Citrate, Sterile CADD for Injection, 2,2500 mcg/50mL in Sterile Water, IntegraDose Compounding Services LLC, 3650 Victorie St N, Suite 900, Shoreview, MN, NDC 71139-6030-1.
Subpotent Drug
May 27, 2026
Atomoxetine Capsules HCL, 10 mg Capsules in unit dose foil strip, strips are packed in cartons of 100, Rx Only, Pkg by: Safecor, Columbus, OH 43204. NDC: 64380-474-01
Labeling: Label Mix-Up: Atomoxetine HCl 25mg Capsule incorrectly labeled as Atomoxetine HCl 10mg Capsule.
May 27, 2026
Primidone Tablets, USP, 50 mg, 50-count bottle, RX only, Manufactured by: Lannett Company, Inc., Marketed by: GSMS, Incorporated, Camarillo, CA 93012. NDC 51407-637-05
Cross contamination with other products: API contaminated with trace amounts of Acemetacin API.
May 27, 2026